Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$30.12+1.82 (+6.43%)
Close on Nov 13, 2026Market cap $1.13BP/E –Yield –
Harrow operating margin
Operating margin is operating income as a percentage of revenue.
Harrow's operating margin for the twelve months ending Sep 30, 2026 was -2.0%. For fiscal 2025 it was 11.2%, against 4.4% the year before. The highest annual figure on record is 11.2% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.2% | +6.8 |
| FY2024 | Dec 31, 2024 | 4.4% | +4.1 |
| FY2023 | Dec 31, 2023 | 0.3% | −1.8 |
| FY2022 | Dec 31, 2022 | 2.2% | −0.1 |
| FY2021 | Dec 31, 2021 | 2.2% | +1.4 |
| FY2020 | Dec 31, 2020 | 0.8% | +10.2 |
| FY2019 | Dec 31, 2019 | -9.4% | +3.2 |
| FY2018 | Dec 31, 2018 | -12.6% | +32.8 |
| FY2017 | Dec 31, 2017 | -45.4% | +34.2 |
| FY2016 | Dec 31, 2016 | -79.6% | +72.9 |
| FY2015 | Dec 31, 2015 | -152.6% | +458.7 |
| FY2014 | Dec 31, 2014 | -611.3% | +76257.5 |
| FY2013 | Dec 31, 2013 | -76868.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 11.6% | −9.0 |
| Q2 FY2026 | Jun 30, 2026 | -15.6% | −33.5 |
| Q1 FY2026 | Mar 31, 2026 | -50.0% | −26.5 |
| Q4 FY2025 | Dec 31, 2025 | 17.5% | −1.8 |
| Q3 FY2025 | Sep 30, 2025 | 20.6% | +17.9 |
| Q2 FY2025 | Jun 30, 2025 | 17.9% | +14.8 |
| Q1 FY2025 | Mar 31, 2025 | -23.5% | −3.5 |
| Q4 FY2024 | Dec 31, 2024 | 19.3% | +32.7 |
| Q3 FY2024 | Sep 30, 2024 | 2.7% | −2.4 |
| Q2 FY2024 | Jun 30, 2024 | 3.1% | −3.9 |
| Q1 FY2024 | Mar 31, 2024 | -20.0% | −24.7 |
| Q4 FY2023 | Dec 31, 2023 | -13.4% | −4.7 |
| Q3 FY2023 | Sep 30, 2023 | 5.1% | +5.5 |
| Q2 FY2023 | Jun 30, 2023 | 7.0% | −0.2 |
| Q1 FY2023 | Mar 31, 2023 | 4.6% | −4.9 |
| Q4 FY2022 | Dec 31, 2022 | -8.7% | −0.1 |
| Q3 FY2022 | Sep 30, 2022 | -0.4% | +19.5 |
| Q2 FY2022 | Jun 30, 2022 | 7.2% | −15.7 |
| Q1 FY2022 | Mar 31, 2022 | 9.5% | −9.4 |
| Q4 FY2021 | Dec 31, 2021 | -8.7% | −26.7 |
| Q3 FY2021 | Sep 30, 2021 | -19.9% | −31.0 |
| Q2 FY2021 | Jun 30, 2021 | 23.0% | +62.8 |
| Q1 FY2021 | Mar 31, 2021 | 18.9% | +24.2 |
| Q4 FY2020 | Dec 31, 2020 | 18.0% | +10.6 |
| Q3 FY2020 | Sep 30, 2020 | 11.1% | +45.6 |
| Q2 FY2020 | Jun 30, 2020 | -39.8% | −34.2 |
| Q1 FY2020 | Mar 31, 2020 | -5.3% | −0.8 |
| Q4 FY2019 | Dec 31, 2019 | 7.3% | +26.3 |
| Q3 FY2019 | Sep 30, 2019 | -34.5% | −28.4 |
| Q2 FY2019 | Jun 30, 2019 | -5.7% | +0.3 |
| Q1 FY2019 | Mar 31, 2019 | -4.5% | +15.6 |
| Q4 FY2018 | Dec 31, 2018 | -19.0% | +10.3 |
| Q3 FY2018 | Sep 30, 2018 | -6.0% | +36.6 |
| Q2 FY2018 | Jun 30, 2018 | -6.0% | +38.0 |
| Q1 FY2018 | Mar 31, 2018 | -20.1% | +49.3 |
| Q4 FY2017 | Dec 31, 2017 | -29.3% | +31.2 |
| Q3 FY2017 | Sep 30, 2017 | -42.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -44.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -69.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -60.6% | – |
See a number that looks wrong?